Novartis Hellas: Vision & Responsibility for the Patients

Transcription

1 Novartis Hellas: Vision & Responsibility for the Patients Foteini Bampanara Head of Communications, Leadership Team member 6 th Annual CSR Capital Link Congress June 27 th 2016

2 Disclaimer 2

3 OUR MISSION: To discover new ways to improve and extend people s lives 3

4 We operate with responsibility and transparency We focus on two pillars: Broaden access to healthcare Access for more patients Strive for controlling and elimination of diseases Promote new healthcare standards Develop innovative treatments Responsible business Folllow ethical and και sustainable business practices Take care of our people Support the need for high ethical standards, control and transparency Fight for environmental sustainability 4 4

5 The 4 basic pillars of NVS Hellas Corporate Responsibility, with Vision & Responsibility for the Patients Patients Business Ethics Our people and society Care for the environment We improve patients quality of life, implement innovative healthcare access programs We operate with responsibility, integrity, and transparency, committed to high ethical standards We are an integral part of the societies we operate in We aim at sustainable use of natural resources eliminating our energy footprint 5 5

6 Patient Declaration 6

7 Patients & Communities in Greece Awareness & Prevention Free medical examinations to citizens across the country Awareness Campaigns Donations / Sponsorships Support of Patient Advocacy Groups Donation of medicines to Social Pharmacies & NGOs Clinical Trials Support of research through clinical trials 1 st in Greece 104 9,3 mio clinical trials investment 7

8 Patients Corporate Responsibility initiatives, which we are proud of 8

9 Our step forward Bring to life our public commitment to patients in a tangible and relevant way Create a road map about the patients rights in our country: Update them about legislation changes and support them to understand the impact in a friendly & easy to access way Implementation of an Awareness campaign, which covers 3 key issues* for the patients: HC access Clinical trials Safety & Quality *Topics were selected based on materiality analysis conducted by EY in Feb for NVS Hellas CR report 9

10 Issue 1: Access to HC (April-May 2016) Medialization (Paid & earned) Online Hub Ads & banners Radio spots Events Auspice by Scientific Organization (Regulatory requirement) Creative identity-messaging: Right to health Cross functional collaboration: Pharma Comms &PAREL/Medical/DRA/Pax/Compliance/IT/Quality/Sourcing External legal advisor to monitor legislative changes 10

11 Patient engagement & inclusion Preview of the campaign before launch to 20 Patient Associations, during a tailor-made capability workshop, co-organized with the No1 local health portal Follow-up letters to all PAGs, presenting the initiative and requesting feedback prior to launch Foteini Bampanara, Head of Comms & PAREL PAGs input was incorporated in the final campaign materials Varvara Baroutsou, Chief CSO 11

12 Key Campaign materials Print ads & Radio spots Do I have the right to health if uninsured? Do I have the right to have a copy of my medical file from the hospital? 12

13 Online Hub The website contains: European Chart of Patient Rights The Patient Rights The Rights of the Hospitalized Patient The Patient Rights Campaign Novartis Patient Declaration Frequently Asked Questions 13

14 Our People Community Partnership Day 340 participants 400 meals 600 kits for refugees 14

15 Our social footprint More than 3 million euros invested in Corporate Responsibility Programs free medical examinations for citizens through Life Measurements program in 2015 Up to 400 patients in early access programs 500 employees 100 million euros return to society (taxes, payroll, investments) 104 clinical trials with more than 9 million euros investment Support more than 35 Patient Advocacy Groups 15

16 Our distinctions 16

17 Thank you